Related Experiment Video
Updated: Jul 10, 2026
08:36
Functional Neuroimaging Using Ultrasonic Blood-brain Barrier Disruption and Manganese-enhanced MRI
Published on: July 12, 2012
Neuronal dysfunction of a long projecting multisynaptic pathway in response to methamphetamine using
Yi-Hua Hsu1, Chiao-Chi V Chen, Anil Zechariah
1Functional and Micro-Magnetic Resonance Imaging Center, Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan, Republic of China.
Psychopharmacology
|November 15, 2007
Summary
Manganese-enhanced MRI (MEMRI) visualized how methamphetamine (MA) disrupts neural pathways. This technique shows functional changes in the brain after drug exposure, offering a new tool for neuropharmacology research.
Area of Science:
- Neuroscience
- Pharmacology
- Medical Imaging
Background:
- Manganese (Mn2+)-enhanced magnetic resonance imaging (MEMRI) is an advanced in vivo imaging technique.
- MEMRI can characterize functional alterations in neural circuits affected by drug challenges.
Purpose of the Study:
- To develop and validate MEMRI for neuropharmacology.
- To visualize functional changes in the fasciculus retroflexus (FR) pathway affected by methamphetamine (MA).
Main Methods:
- Rats received repeated intraperitoneal injections of MA or saline.
- Manganese (Mn2+) was injected into the habenular nucleus (FR origin).
- MEMRI was performed over 48 hours to assess Mn2+ uptake across key brain regions.
Main Results:
- Methamphetamine (MA) altered Mn2+ uptake complexity and efficiency in the ventral tegmental area (VTA) via the FR tract.
- Significantly increased Mn2+ accumulation was observed in the VTA, striatum, and prefrontal cortex (PFC) in MA-treated rats.
Conclusions:
- MEMRI successfully visualized disruptions in the multisynaptic pathway following repeated MA exposure.
- MEMRI shows promise as a method for investigating drug-induced functional neural pathway changes in vivo.
